American Thyroid Association Design and Feasibility of a Prospective Randomized Controlled Trial of Prophylactic Central Lymph Node Dissection for Papillary Thyroid Carcinoma
- 1 March 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 22 (3), 237-244
- https://doi.org/10.1089/thy.2011.0317
Abstract
Background: The role of prophylactic central lymph node dissection in papillary thyroid cancer (PTC) is controversial in patients who have no pre- or intraoperative evidence of nodal metastasis (clinically N0; cN0). The controversy relates to its unproven role in reducing recurrence rates while possibly increasing morbidity (permanent hypoparathyroidism and unintentional recurrent laryngeal nerve injury). Methods and Results: We examined the design and feasibility of a multi-institutional prospective randomized controlled trial of prophylactic central lymph node dissection in cN0 PTC. Assuming a 7-year study with 4 years of enrollment, 5 years of average follow-up, a recurrence rate of 10% after 7 years, a 25% relative reduction in the rate of the primary endpoint (newly identified structural disease; i.e., persistent, recurrent, or distant metastatic disease) with central lymph node dissection and an annual dropout rate of 3%, a total of 5840 patients would have to be included in the study to achieve at least 80% statistical power. Similarly, given the low rates of morbidity, several thousands of patients would need to be included to identify a significant difference in rates of permanent hypoparathyroidism and unintentional recurrent laryngeal nerve injury. Conclusion: Given the low rates of both newly identified structural disease and morbidity after surgery for cN0 PTC, prohibitively large sample sizes would be required for sufficient statistical power to demonstrate significant differences in outcomes. Thus, a prospective randomized controlled trial of prophylactic central lymph node dissection in cN0 PTC is not readily feasible.Keywords
This publication has 27 references indexed in Scilit:
- Prophylactic Central Neck Dissection and Local Recurrence in Papillary Thyroid Cancer: A Meta-analysisAnnals of Surgical Oncology, 2010
- Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancerCurrent Opinion in Oncology, 2010
- Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid CancerThyroid®, 2009
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinomaSurgery, 2008
- Micrometastases in thyroid cancer. An important finding?Surgical Oncology, 2008
- PARATHYROID HORMONE ASSAY PREDICTS HYPOCALCAEMIA AFTER TOTAL THYROIDECTOMYAnz Journal of Surgery, 2007
- Influence of surgical and postoperative treatment on survival in differentiated thyroid cancerBritish Journal of Surgery, 2007
- Lymph node surgery in papillary thyroid carcinomaJournal of the American College of Surgeons, 2003